<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:department>Food and Nutritional Sciences</gtr:department><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/592A8843-A09A-4EB9-B524-466F79424AB4"><gtr:id>592A8843-A09A-4EB9-B524-466F79424AB4</gtr:id><gtr:name>Unilever UK</gtr:name><gtr:address><gtr:line1>100 Victoria</gtr:line1><gtr:line2>Embankment</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>EC4Y 0DY</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/814526DD-56F5-4534-BED5-DB7F67BC83F7"><gtr:id>814526DD-56F5-4534-BED5-DB7F67BC83F7</gtr:id><gtr:firstName>Kim</gtr:firstName><gtr:otherNames>Geraldine</gtr:otherNames><gtr:surname>Jackson</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C52C110D-F68B-4483-9D61-9E82F514D0AD"><gtr:id>C52C110D-F68B-4483-9D61-9E82F514D0AD</gtr:id><gtr:firstName>Anne Marie</gtr:firstName><gtr:surname>Minihane</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B7E1D8D5-EB05-4A64-9BC2-AB32F3EBE1EA"><gtr:id>B7E1D8D5-EB05-4A64-9BC2-AB32F3EBE1EA</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Fry</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9A95E0D8-064D-4AFE-BAC0-F5F917B7272F"><gtr:id>9A95E0D8-064D-4AFE-BAC0-F5F917B7272F</gtr:id><gtr:firstName>Christine</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FE021816%2F1"><gtr:id>B1B17A3F-2F8B-4E0C-8A5B-0E4BDFC4F69D</gtr:id><gtr:title>In vivo and in vitro studies of dietary fatty acids eNOS polymorphisms and insulin resistance in the endothelium</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E021816/1</gtr:grantReference><gtr:abstractText>The hormone insulin is involved in stimulating the uptake and metabolism of dietary carbohydrates (e.g. sugars) and fats by cells such as those in muscle, fat tissue and liver. When insufficient insulin is produced (type 1 diabetes), or when there is lack of effect of insulin on cells (type 2 diabetes and insulin resistance), the metabolism of carbohydrates and fats becomes abnormal. Levels of blood glucose rise, leading to symptoms of diabetes (thirst, tiredness etc) and blood lipids also rise. Lipids are carried in the blood on complex particles called lipoproteins (e.g. LDL and HDL cholesterol). In diabetes these particles are abnormal, with low HDL cholesterol (good cholesterol) and raised concentrations of particles called triglyceride rich lipoproteins. This combination is known to increase the risk of cholesterol penetrating the blood vessel wall, leading to hardening of the arteries and heart disease. For a long time it was thought that the reason people with diabetes have a much higher risk of heart disease was because of these abnormal lipoprotein particles. Whilst this is undoubtedly part of the story, new research is suggesting other mechanisms may also be involved. Although we have known for a long time that cells such as muscle, fat and liver require insulin, it is only recently that insulin has been shown to be required for the normal healthy functioning of the cells that line the blood vessel wall (called endothelial cells). Insulin increases the formation of compounds which keep the blood vessel wall dilated and reduces release of compounds which constrict the blood vessel wall and cause it to become sticky (called inflammatory proteins). This new research is helping to understand how insulin triggers the release of compounds which keep the vessel wall healthy and what happens when people become resistant to the normal actions of insulin. People who are diabetic or insulin resistant are unable to dilate their blood vessels normally when stimulated and release inflammatory proteins which are more likely to lead to cholesterol depositing in the artery wall. The reason there is increasing concern about insulin resistance is that this condition is becoming extremely common because it is linked with overweight and obesity. It is now estimated that as many as 20% of middle aged adults may be insulin resistant and this greatly increases their risk of getting heart disease or having a stroke. Understanding the consequences of insulin resistance in blood vessel cells is therefore very important. Some research has shown that the types of fats in the diet can influence the efficiency with which insulin acts on muscle, fat and liver cells. However very little is known about how the type of dietary fat influences endothelial cells and how the cells behave when exposed to different fats, both in the body and when studied in test tubes. We will use a technique to study the behavior of blood vessels in people when they are exposed to high concentrations of different types of fats and also how it affects their blood vessel response when insulin is given. We will also study cells cultured in the laboratory to see if we can understand the triggers that lead to the cells responding more or less favourably in the presence of different types of fats. One of the compounds which help the blood vessel wall to dilate is a small molecule called nitric oxide. The enzyme which leads to the release of nitric oxide is a protein whose structure varies slightly in some people due to differences in their genes (about 12% the population carry this variation and are known to be more at risk of heart disease). We want to study people with and without this variation and see if they respond differently to different fats. We will also study blood vessel cells (from the umbilical cord) which have been obtained from women with and without the variant to see how this enzyme works.</gtr:abstractText><gtr:technicalSummary>Endothelial dysfunction is a characteristic feature of insulin resistance which is thought to arise largely from impaired generation of the vasodilator, nitric oxide (NO), by vascular endothelial cells. Recent cell studies have suggested impaired release of NO in insulin resistance is due to selective resistance to the action of insulin on the Insulin Receptor Substrate-1 (IRS-1) /Phosphoinositide 3-kinase (PI 3K) / Akt pathway, and attenuation of the activation of endothelial nitric oxide synthase (eNOS) and NO production. Furthermore, studies have shown this pathway to be down regulated by the serine phosphorylase IKKB, and that high concentrations of free fatty acids (FFAs) activate IKKB, as well as leading to activation of pro-inflammatory payways via NFKB and MAP kinase. The aims of the proposed programme of work, which builds on recent studies in our group, is to investigate the relevance of these in vitro findings by means of a series of in vivo studies in which we will evalute the effect of elevated circulating concentrations of specific fatty acids on vascular function measured using Laser Doppler Iontophoresis. We will carry out these studies in normal healthy subjects who carry the common variant (Glu/Glu) of the eNOS gene polymorphism Glu298Asp as well as in subjects carrying the rarer isoform (Asp/Asp). We will carry out parallel cell studies to evaluate the effect of a range of fatty acids on the activation of the Insulin Receptor Substrate-1 (IRS-1) /Phosphoinositide 3-kinase (PI 3K) / Akt pathway/ eNOS pathway, using human umbilical vein cells (HUVECs) from subjects carrying the common and rare isoforms of eNOS Glu298Asp and/or HUVECs transfected with the relevant DNA sequences. The studies will provide evidence for likely benefit of modifying dietary fat quality on insulin resistance and endothelial dysfunction, contributing to more effective and scientifically sound approaches to diet and vascular health.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>350372</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Unilever</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BBSRC Industry Interchange Programme 2008. Development of mathematical models of lipid metabolism in the fed state. &amp;pound;32,500</gtr:description><gtr:id>78CA03F2-0B5A-4F5F-A8B2-77ABF51A8C46</gtr:id><gtr:impact>Six full research papers</gtr:impact><gtr:outcomeId>5461f8bc3895b3.43639165-1</gtr:outcomeId><gtr:partnerContribution>Provided finance to support software, data entry and specialist support to maintain the data base</gtr:partnerContribution><gtr:piContribution>To develop a shared data base of human postprandial metabolic data including that obtained from the present grant</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media interest</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9DD3532-64C6-4835-A9EB-AD8C4AFCBD0E</gtr:id><gtr:impact>Media interest included calls from international media

None</gtr:impact><gtr:outcomeId>546201a83a2ef4.09233083</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.reading.ac.uk/news-and-events/releases/PR468558.aspx</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D1940A66-83D3-4684-958C-C769C85A6CA4</gtr:id><gtr:title>A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.</gtr:title><gtr:parentPublicationTitle>Contraception</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/999687d55125e86a896669e3c6298d53"><gtr:id>999687d55125e86a896669e3c6298d53</gtr:id><gtr:otherNames>Meendering JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0010-7824</gtr:issn><gtr:outcomeId>5461f08c4eff27.33109697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2F83E6D-7838-4EDD-B989-8A45C3B6EFFF</gtr:id><gtr:title>Effect of the endothelial nitric oxide synthase Glu298Asp polymorphism on endothelial function and lipid profile in healthy subjects</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4e4f3b8a031ee57e24097d548551a08"><gtr:id>c4e4f3b8a031ee57e24097d548551a08</gtr:id><gtr:otherNames>AK Thompson</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>5461f3398bf2a8.89157033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0189B8EB-DE6B-496D-90F0-AE8163841158</gtr:id><gtr:title>Endothelial function and insulin sensitivity during acute non-esterified fatty acid elevation: Effects of fat composition and&amp;nbsp;gender.</gtr:title><gtr:parentPublicationTitle>Nutrition, metabolism, and cardiovascular diseases : NMCD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85dae0342a55b316ca95da7ba6181b20"><gtr:id>85dae0342a55b316ca95da7ba6181b20</gtr:id><gtr:otherNames>Newens KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0939-4753</gtr:issn><gtr:outcomeId>5461f1ce8e4019.69137996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>146037A9-57F4-4BF5-B20B-1E300C631680</gtr:id><gtr:title>Glu298Asp polymorphism influences the beneficial effects of fish oil fatty acids on postprandial vascular function.</gtr:title><gtr:parentPublicationTitle>Journal of lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfe2e33950541977b889f586d5bcd82c"><gtr:id>cfe2e33950541977b889f586d5bcd82c</gtr:id><gtr:otherNames>Thompson AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2275</gtr:issn><gtr:outcomeId>5461ebd13f89f7.97404079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>735AE08A-8AB2-435B-B71A-22B8061F7F62</gtr:id><gtr:title>P333 Dietary fatty acids influence endothelial function during acute NEFA elevation.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/293f64a6d0c7fbbe17b48414b838bbcc"><gtr:id>293f64a6d0c7fbbe17b48414b838bbcc</gtr:id><gtr:otherNames>A Thompson</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5461f562255877.83822312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50F34073-E731-4E4A-8F96-4FA29040F8D9</gtr:id><gtr:title>Acute effects of elevated NEFA on vascular function: a comparison of SFA and MUFA.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85dae0342a55b316ca95da7ba6181b20"><gtr:id>85dae0342a55b316ca95da7ba6181b20</gtr:id><gtr:otherNames>Newens KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>5461f025cd6da4.13787875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>387000C7-5453-4540-A6D5-44BAA3EB424F</gtr:id><gtr:title>Effect of raised non-esterified fatty acid levels on endothelial function is modified by fatty acid composition.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4e4f3b8a031ee57e24097d548551a08"><gtr:id>c4e4f3b8a031ee57e24097d548551a08</gtr:id><gtr:otherNames>AK Thompson</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5461f4ddea3a25.44138366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F92E38D8-E275-4EC6-AB08-6BFC3E4A9E32</gtr:id><gtr:title>DHA-rich fish oil reverses the detrimental effects of saturated fatty acids on postprandial vascular reactivity.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85dae0342a55b316ca95da7ba6181b20"><gtr:id>85dae0342a55b316ca95da7ba6181b20</gtr:id><gtr:otherNames>Newens KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>5461efc17df903.64599317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1D6333B-10DE-4984-A14E-CBB05A9E24A7</gtr:id><gtr:title>Minimum recovery time between reactive hyperemia stimulus in the repeated measurement of brachial flow-mediated dilatation.</gtr:title><gtr:parentPublicationTitle>Ultrasound in medicine &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e63efde4aa0edaa92b0ccccbd4c785f"><gtr:id>5e63efde4aa0edaa92b0ccccbd4c785f</gtr:id><gtr:otherNames>Barton M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0301-5629</gtr:issn><gtr:outcomeId>5461ed5d7864c1.92946921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1216DB37-317A-467B-8083-907BB4387480</gtr:id><gtr:title>Abstract: P459 IMPACT OF ELEVATED FREE FATTY ACIDS ON INSULIN AND MARKERS OF INFLAMMATION AND ENDOTHELIAL FUNCTION</gtr:title><gtr:parentPublicationTitle>Atherosclerosis Supplements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fa107692daeb1de067a4319da62f931"><gtr:id>7fa107692daeb1de067a4319da62f931</gtr:id><gtr:otherNames>Newens K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>5461f5ed649e01.30568815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB2E5044-F0EE-4E65-8432-D8BCB1973E32</gtr:id><gtr:title>Insulin sensitivity during acute elevation of non-esterified fatty acids: Influence of fat composition and gender.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b3fe56de3ce4a008baf5bb454644146"><gtr:id>5b3fe56de3ce4a008baf5bb454644146</gtr:id><gtr:otherNames>KJ Newens</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5461f44693e4a5.19640847</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E021816/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>